Skip to search formSkip to main contentSkip to account menu

YM 934

Known as: YM-934, YM934 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
We compared the effect of an ATP-sensitive potassium channel opener, YM934, with that of nitroglycerin (NTG) on impaired coronary… 
2003
2003
To compare in vivo the efficacy, potency, and bladder–vascular selectivity of ATP‐sensitive potassium channel openers (KCOs… 
1999
1999
The present study was undertaken to examine whether the ATP-sensitive potassium channel opener, YM934, would be effective in… 
1998
1998
In this phase I study a novel potassium channel opener (YM934) was administered to young healthy male volunteers to identify a… 
1997
1997
1. Effects of the anticholinergic agents atropine, oxybutynin, and terodiline, and the potassium channel openers YM934 (2-(3,4… 
1997
1997
Abstract The effect of YM934 (2-(3,4-dihydro-2,2-dimethyl-6-nitro-2H-1,4-benzoxazin-4-yl)pyridine N-oxide) on airway… 
1996
1996
YM934 is a novel synthetic potassium‐channel opener. We have investigated its anti‐asthma effect after intravenous (i.v.) and… 
1995
1995
The effect of YM934 (2-(3,4-dihydro-2,2-dimethyl-6-nitro-2H-1,4-benzoxazin-4-yl)pyridine N-oxide) on non-adrenergic non… 
1994
1994
The effect of a potassium channel opener, YM 934, on neurogenic airway plasma leakage was examined in anesthetized guinea pigs…